Zynerba Press Releases

12 Dec 18
Zynerba Pharmaceuticals Announces Sustained Improvements in Emotional and Behavioral Symptoms of Fragile X Syndrome through 12 Months of Treatment with ZYN002

20 Nov 18
Zynerba Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference

8 Nov 18
Zynerba Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights

11 Oct 18
Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum

26 Sep 18
Zynerba Pharmaceuticals to Present at the Cantor Global Healthcare Conference

31 Aug 18
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference

2 Aug 18
Zynerba Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights

1 Aug 18
Zynerba Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference

31 Jul 18
Zynerba Pharmaceuticals to Host Conference Call to Provide Second Quarter 2018 Business Update

20 Jul 18
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock